Development status: Experimental

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Disrupts the maintainance of an electrochemical gradient across the membrane. Activity against E. coli, Acinetobacter and Mycobacterium tuberculosis

Additional information: Synthetic compound; repurposed c-Jun N-terminal kinase inhibitor SU3327 (diabetic treatment) through machine learning modeling and experimental design.